GlassScriptPhysician profile
Scott M Haskins
NPI 1770878142
$9,302.95
in general payments reported to CMS, 2019-2025
11 companies · $1,974 in 2025
The $1,974 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,236 · 2020: $134 · 2021: $69.14 · 2022: $1,922 · 2023: $1,351 · 2024: $617 · 2025: $1,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,530 · Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,530.24 |
| Food and Beverage | $1,411.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,297.23 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $1,733.43 | 2019-2025 | Rosa, Comprehensive Shoulder System, Persona |
| Great Lakes Orthopedics | $971.07 | 2019 | |
| True North Surgical INC | $627.18 | 2022-2025 | |
| Depuy Synthes Sales INC. | $224.94 | 2020-2022 | |
| Smith+Nephew, INC. | $186.01 | 2019 | |
| Horizon Therapeutics Plc | $125.08 | 2019 | |
| Medtronic, INC. | $85.08 | 2021-2024 | Intellis Adaptivestim |
| Stryker Corporation | $25.87 | 2025 | Aequalis Perform Reversed |
| Novo Nordisk INC | $14.67 | 2025 | |
| Allergan, INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Haskins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.